RR1

3.57%

1.5¢ reach resources limited

Your post has done the same

First 32 Last

Share
Profile

Follow
roblun

5,731 Posts.

2248

20/10/23

15:00

Post #: 70451767
Share

Originally posted by Maverick7: ↑

WARNING: the following will trigger some holders

1. Li results were originally scheduled for early Oct, then mid-Oct, now early Nov. Looks very suspicious, especially considering it wouldn't be a good look at the conference if they released poor results this week and the share price had taken a big fall. Anyone with experience knows that good news is usually reported immediately, whereas bad news usually is delayed as long as possible, yes it's technically illegal, but most junior resource companies operate this way. Also, they would likely already be in receipt of a large portion (if not all) of their results as labs usually dispatch results in batches on a FIFO basis.

2. Mentioning that they're going to get any expert geochemist to analyse the results and ratios is also not a good sign as probably means the Li results were not good, so they're going to try pad the results to soften the blow with ratios to try give hope that they might find something better later.

3. He didn't look and sound very confident when he mentioned the upcoming results.

4. The market cap is relatively high for their stage of exploration, so if results are poor expect a large fall possibly to 0.5/0.6c as other Li cos have been hammered after releasing poor results.

I may be wrong, just my 2 cents as a paid down-ramper.

PS: @Yevgeny ask EFE holders if they think @TheArchitect was a bonus
PPS: @roblun constantly pasting copious pages from announcements unnecessarily clogs the forum and provides minimal value, please summarise instead, thanks.

Expand

Your post has done the same

Last edited by roblun: 20/10/23

RR1 Price at posting: 1.2¢ Sentiment: Buy Disclosure: Held
19 Upvote

1 Great analysis

Reply

Top Stories

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

BUX

Buxton projects new graphite province discovery at WA Narryer play

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 17 more messages in this thread...

First 32 Last

Add RR1 (ASX) to my watchlist

(20min delay)
Last 1.5¢		Change 0.001(3.57%)		Mkt cap ! $12.67M

Open	High	Low	Value	Volume
1.4¢	1.5¢	1.4¢	$4.858K	335.1K

Buyers (Bids)

No.	Vol.	Price($)
2	173843	1.4¢

Sellers (Offers)

Price($)	Vol.	No.
1.5¢	1444267	8

View Market Depth

No.	Vol.	Price($)
2	173843	0.014
3	572794	0.013
2	500000	0.012
8	1210909	0.011
5	836271	0.010

Price($)	Vol.	No.
0.015	1444267	8
0.016	562000	3
0.017	240479	3
0.018	166694	2
0.019	306667	3

Last trade - 11.19am 04/10/2024 (20 minute delay)

RR1 (ASX) Chart

Your post has done the same

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Your post has done the same

Top Stories

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News